Cargando…

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions

BACKGROUND: Elevation of liver enzymes in rheumatoid arthritis patients treated with tocilizumab (Actemra(®)) or anakinra (Kineret(®)) is a well-documented phenomenon. However, characterization of liver histology has not been defined in most cases. Similarly, the factors involved in decisions regard...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahamid, Mahmud, Mader, Reuven, Safadi, Rifaat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262392/ https://www.ncbi.nlm.nih.gov/pubmed/22287855 http://dx.doi.org/10.2147/CPAA.S24004

Ejemplares similares

Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
por: Mahamid, Mahmud, et al.
Publicado: (2011)

Anakinra/tocilizumab: Primary biliary cholangitis: case report
Publicado: (2021)

Anakinra and hepatotoxicity in pediatric rheumatology: a case series
por: Martins, Frederico Rajão, et al.
Publicado: (2023)

Anakinra Hepatotoxicity in a Patient With Adult-Onset Still's Disease
por: Ahmed, Osman, et al.
Publicado: (2015)

Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease
por: Shteyer, Eyal, et al.
Publicado: (2016)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2019)

Rheumatoid Arthritis
por: Follmar, Keith E., et al.
Publicado: (2013)

Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
por: Negoescu, Andra F., et al.
Publicado: (2014)

Tocilizumab and liver injury in patients with COVID-19
por: Serviddio, Gaetano, et al.
Publicado: (2020)

Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study
por: KÜÇÜKŞAHİN, Orhan, et al.
Publicado: (2022)

Turmeric-Induced Hepatotoxicity: Report of 2 Cases
por: Sohal, Aalam, et al.
Publicado: (2021)

Review of tocilizumab in the treatment of rheumatoid arthritis
por: Okuda, Yasuaki
Publicado: (2008)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014)

Tocilizumab: A Review in Rheumatoid Arthritis
por: Scott, Lesley J.
Publicado: (2017)

Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010)

Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis
por: Anada, Mamiko, et al.
Publicado: (2020)

Tocilizumab for refractory morphea in adults: A case series
por: Lonowski, Sarah, et al.
Publicado: (2022)

Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES)
por: Stredny, Coral M., et al.
Publicado: (2020)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Comparison of Anakinra and Tocilizumab in Anticytokine Therapy in the Treatment of Coronavirus Disease-2019
por: Ozkan, Feyza, et al.
Publicado: (2022)

Tocilizumab Was Effective in Repairing the Large Geode in a Patient with Rheumatoid Arthritis
por: Izumiyama, Takuya, et al.
Publicado: (2020)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Platelet Rich Plasma for Treatment of Rheumatoid Arthritis: Case Series and Review of Literature
por: Badsha, Humeira, et al.
Publicado: (2020)

Concurrence of Rheumatoid Arthritis and Ankylosing Spondylitis: Analysis of Seven Cases and Literature Review
por: Flores-Robles, Bryan-Josué, et al.
Publicado: (2022)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors
por: Bouazzi, Omaima El, et al.
Publicado: (2016)

A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
por: Cai, Shaozhe, et al.
Publicado: (2020)

Tocilizumab versus anakinra in COVID-19: results from propensity score matching
por: Arcani, Robin, et al.
Publicado: (2023)

Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease
por: Amer, Johnny, et al.
Publicado: (2018)

Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis
por: Sato, Tomohito, et al.
Publicado: (2014)

Acute Generalized Exanthematous Pustulosis due to Tocilizumab in a Rheumatoid Arthritis Patient
por: Izquierdo, J. H., et al.
Publicado: (2012)

Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis
por: Szeto, Matthew Chak Hin, et al.
Publicado: (2016)

A Rare Case of Rheumatoid Arthritis with Tocilizumab-induced Intestinal Mucosal Injury
por: Ohkubo, Akito, et al.
Publicado: (2021)

Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series
por: Basnet, Ajaya, et al.
Publicado: (2022)

Management of rheumatoid arthritis in People’s Republic of China – focus on tocilizumab and patient considerations
por: Wang, Geng, et al.
Publicado: (2015)

Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab
por: Yilmaz, Sedat, et al.
Publicado: (2013)

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

Tocilizumab-Induced Dermatosis in a Patient With Rheumatoid Arthritis
por: Babkoor, Doaa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3hje7u2l25rv0559n269h87inf